The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.
All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.
Executive Industry Advisor, Medidata Solutions
ACRO Chair & CEO, Labcorp Drug Development
Chief Development Officer & Global Head Clinical Development Solutions, Syneos Health
President, R&DS Design & Delivery Innovation, IQVIA
Chief Technology & Product Officer, Saama Technologies
ACRO Vice-Chair & SVP & GM, Oracle Health Sciences
Chief Marketing Officer, Signant Health
Chief Operating & Growth Officer, Parexel
Chief Clinical Trial Officer, Florence Healthcare
Chief Medical Officer, PPD Clinical Research, Thermo Fisher Scientific
President & CEO, Clario
Vice President, R&D Strategy, Veeva Systems
Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.
Senior Vice President, Global Regulatory Policy
Chief Operating Officer
Director of Government Relations
Membership and Communications Coordinator